Where is Panacea located?

Panacea is headquartered in Douglas, United Kingdom.

How many employees does Panacea have?

As of Jul 01, 2024, the latest employee count at Panacea is 11 - 50.

Is Panacea a funded company?

Panacea is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Panacea rank among its competitors?

Panacea ranks 712th amongst 1689 active competitors, of which 24 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of Panacea?

Panacea's top competitors include Indegene, IntegriChain and ProPharma Group. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

Panacea - 2026 Company Profile & Competitors

Panacea is an acquired company based in Douglas (United Kingdom), founded in 2008. It operates as a Provider of Pharmacovigilance services. The company has 1689 active competitors, including 24 funded and 192 that have exited. Its top competitors include companies like Indegene, IntegriChain and ProPharma Group.

Company Details

Panacea offers pharmacovigilance services and a host of regulatory affairs services at the clinical trial, marketing authorisation and post-authorisation stages for drugs and medical devices. The company's service portfolio includes supply of EU Qualified Person for Pharmacovigilance (QPPV), Preparation and Maintenance of Pharmacovigilance System Master File (PSMF) and Risk Management Plans (RMP), Medical Information provisions and ICSR ( Individual case safety report ) submission via EVWEB, and the setup and maintenance of Safety Data Exchange Agreements (SDEA). The company was shortlisted for the “Industry Partner of the Year” at The Global Generics and Biosimilars Awards 2016, which recognises the achievements of CROs and service providers to the generics and biosimilar industries.

Website: panaceapharmaprojects.com
Social
Email ID: *****@panacea.im

Key Metrics

Founded Year

2008

Location

Douglas, United Kingdom

Stage

Acquired

Ranked

712^th among 1689 active competitors

Employee Count

11 - 50 as on Jul 01, 2024

Similar Companies

ProPharma Group & 423 more

Exit Details

Acquired by Ergomed (Oct 10, 2023)

View Panacea's full profile

Panacea got acquired by Ergomed on Oct 10, 2023.

Click here to take a look at Panacea's acquisition in detail

Panacea has not raised any funding rounds yet.

Panacea's employee count trend

Panacea has 11 - 50 employees as of Jul 24. Here is Panacea's employee count trend over the years:

Uncover Panacea's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Panacea include Indegene, IntegriChain and ProPharma Group. Here is the list of Top 10 competitors of Panacea, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 17 others	76/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	65/100
3rd	ProPharma Group 2001, Saint Paul (United States), Acquired	Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device	-	Apollo Investment Corporation, First Analysis ... & 3 others	65/100
4th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	65/100
5th	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	North Sky Capital, ACE & Company & 2 others	60/100
6th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Intertrust, Bridgepoint Group & 7 others	58/100
7th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	58/100
8th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
9th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	57/100
10th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	T Square Enterprises & 10 others	56/100
712th	Panacea 2008, Douglas (United Kingdom), Acquired	Provider of Pharmacovigilance services	-	-	20/100